A team at UCL’s Institute of Healthy Ageing uses RNAi in Drosophila neurons to knock down the Pol III repressor Maf1. This preserves 5S rRNA transcription and protein synthesis during aging, improving neuromuscular and gut function, and extending female lifespan.
Key points
- Neuron-specific RNAi of Maf1 in adult Drosophila boosts Pol III activity and extends female lifespan.
- Maf1 knockdown prevents age-related decline in 5S rRNA expression and restores puromycin-labeled translation in aged brains.
- Improved neuromuscular function, gut barrier integrity, and partial rescue of C9orf72-repeat toxicity demonstrate broad aging benefits.
Why it matters: Sustaining neuronal protein synthesis via targeted Maf1 suppression offers a novel route to healthy aging and potential neuroprotective therapies.
Q&A
- What is Maf1?
- Why target 5S rRNA specifically?
- How was the Drosophila model used?
- Is this approach relevant to humans?